Skip to Content

SHIRE 465 37.5 mg (Mydayis 37.5 mg)

Generic Name: amphetamine/dextroamphetamine

Pill with imprint SHIRE 465 37.5 mg is Brown & White, Capsule-shape and has been identified as Mydayis 37.5 mg. It is supplied by Shire US, Inc..

Mydayis is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 37.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for SHIRE 465 37.5 mg

Mydayis 37.5 mg SHIRE 465 37.5 mg

Mydayis

Generic Name
amphetamine/dextroamphetamine
Imprint
SHIRE 465 37.5 mg
Strength
37.5 mg
Color
Brown & White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Shire US, Inc.
National Drug Code (NDC)
54092-0474
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, sucrose, magnesium silicate, triethyl citrate, ferric oxide red, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.